Cancer Genetics

ACOG Guidelines

Practice Bulletin 149, Endometrial Cancer

Committee Opinion 409, Direct-to-Consumer Marketing of Genetic Testing

Committee Opinion 478, Family History as a Risk Assessment Tool

Technology Assessment 11, Genetics and Molecular Diagnostic Testing

Practice Bulletin 103, Hereditary Breast and Ovarian Cancer Syndrome

Committee Opinion 634, Hereditary Cancer Syndromes and Risk Assessment

Practice Bulletin 147, Lynch Syndrome

Committee Opinion 527, Personalized Genomic Testing for Disease Risk

Patient Education

BRCA1 and BRCA2 Mutations - This Patient Education Fact Sheet is available for members and non-members in English and Spanish.

Ovarian Cancer - This Patient Education Pamphlet is available in English (members only) and Spanish (members and non-members). This pamphlet is available for purchase.

Additional Resources

BRCA1 and BRCA2: Cancer Risk and Genetic Testing – This resource by the National Institutes of Health (NIH) National Cancer Institute provides information on BRCA1 and BRCA2 gene mutations.

Genetics and Cancer – This resource by the American Cancer Society focuses on the links between genes and cancer.

KNOW: BRCA Tool – This online tool developed by the Centers for Disease Control and Prevention (CDC) helps women understand their risks for having a BRCA1 or BRCA2 gene mutation.

Ordering of Genetic Tests – This position statement, published by ACOG in November 2015, addresses providers’ ability to order genetic tests.

Questions?

Please contact clinical@acog.org.

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998